Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NICU Antibiotics and Outcomes Trial

NCT03997266 is registered in ClinicalTrials.gov with Michael Morowitz as lead sponsor.

NCT NCT03997266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03997266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NICU Antibiotics and Outcomes Trial
Lead sponsor
Michael Morowitz
Phase
Phase 4
Overall status
Completed
Start date
August 5, 2020
Completion date
January 15, 2026
Enrollment
359 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

death; neonatal, early-onset neonatal sepsis, extreme prematurity, late-onset neonatal sepsis, microbial colonization, necrotizing enterocolitis of newborn